Table S2. Comparison of C-indexes between the nomograms, TNM and SEER stages in EOGC patients.
Survival types | Tumor stage types | Training set | Validation set | |||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |||
OS | Nomogram | 0.688 | 0.629–0.747 | 0.633 | 0.579–0.687 | |||
SEER stage | 0.708 | 0.659–0.757 | 0.267 | 0.685 | 0.642–0.728 | 0.198 | ||
TNM 7th stage | 0.769 | 0.717–0.821 | 0.007 | 0.750 | 0.707–0.793 | <0.001 | ||
CSS | Nomogram | 0.785 | 0.735–0.835 | 0.733 | 0.686–0.780 | |||
SEER stage | 0.726 | 0.680–0.772 | 0.035 | 0.690 | 0.646–0.734 | 0.033 | ||
TNM 7th stage | 0.782 | 0.732–0.832 | 0.457 | 0.762 | 0.719–0.805 | 0.366 |
TNM, tumor-node-metastasis; SEER, surveillance, epidemiology and end results; EOGC, early-onset gastric cancer; C-index, concordance index; HR, hazard ratio; CI, confidence intervals; OS, overall survival; CSS, cancer-specific survival.